QEBSEROS
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Nov 2023)
What this means for you
This application is over — abandoned 13 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90003470
- Mark type
- Stylized text
- Filed
- 16 Jun 2020
- Published for opposition
- 18 Aug 2020
- Abandoned
- 13 Nov 2023
- Attorney of record
- Mark D. Simpson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
Owner
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
Prosecution history
- 13 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2023 — SOU EXTENSION 5 GRANTED
- 13 Apr 2023 — SOU EXTENSION 5 FILED
- 20 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Oct 2022 — SOU EXTENSION 4 GRANTED
- 13 Oct 2022 — SOU EXTENSION 4 FILED
- 13 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 31 May 2022 — ASSIGNED TO EXAMINER
- 15 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Apr 2022 — SOU EXTENSION 3 GRANTED
- 13 Apr 2022 — SOU EXTENSION 3 FILED